Post by
Speyeder999 on Jun 15, 2023 8:18pm
Corporate Overview - May 2023
https://d1io3yog0oux5.cloudfront.net/_f34c61df68d6619194d97a763502e5cd/promisneurosciences/db/933/8787/pdf/PMN+Corp+Deck_Final_08May23.pdf
Although I do truly appreciate the regular corporate overview updates, one has to wonder what purpose they serve when certain stated milestones have yet to transpire. Does anyone proof read this before its released?
slide 22 - ''Data expected to be available mid-2023'' really?
slide 25 - ''On track for Phase 1a first subject visit 1H2023'' again, really?
slide 15 - ''PMN310 Clinical data starting in 2023'' Oh, ok (so much clearer now)
slide ??? - ''Required Financing to make all this happen''
Comment by
BottomBroker on Jun 16, 2023 2:07pm
Have to admit, I've lost a lot of confidence and trust in PMN. Might be a glimmer of hope left, but even that's fading.
Comment by
M101 on Jun 16, 2023 4:18pm
It's wearing on me too, but I put myself in the shoes of the Boston Group and this situation suits me fine. 104 shareholders sounds like a private company already but maybe half that is even better for those with deep pockets. Time also lets warrants expire out of the money.